Qiagen NV (NYSE:QGEN)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - QGEN

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - QGEN

  • Market Cap$11.432bn
  • SymbolNYSE:QGEN
  • IndustryHealthcare
  • SectorDiagnostics & Research
  • Currency
  • ISINNL0012169213

Company Profile

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences (52% of 2019 sales) and molecular diagnostics (48% of sales). Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (47%), followed by EMEA (32%) and Asia-Pacific (21%).Qiagen NV provides sample and assay technologies to extract, purify, amplify, and interpret DNA (Deoxyribonucleic acid), RNA (Ribonucleic acid), and proteins. It also offers kits, assays, related automated systems and bioinformatics solutions.

Latest QGEN news

Currently there for this company. Visit our news hub for other news .